Yellow fever disease: Density equalizing mapping and gender analysis of international research output

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  Bundschuh, Matthias ^a   Groneberg, David A ^a   Klingelhoefer, Doris ^a   Gerber, Alexander ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; EMPLOYMENT; FRANCE; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; UNITED KINGDOM; UNITED STATES; YELLOW FEVER;

ANIMALS; BIBLIOMETRICS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTERNATIONALITY; MALE; PUBLISHING; RESEARCH; SEX FACTORS; YELLOW FEVER;

EID: 84887713967     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-331     Document Type: Article

References (38)

1. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review. Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, Vaccine 2011 29 4544 4555 10.1016/j.vaccine.2011.04.055 21549787
2. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever (vol 11, pg 622, 2011). Jentes ES, Lancet Infect Dis 2012 12 98 98
3. Methodology for Definition of Yellow Fever Priority Areas, Based on Environmental Variables and Multiple Correspondence Analyses. Moreno ES, Barata RDB, Plos Neglect Trop D 2012 6 7 1 7
4. Epidemiological and laboratory characterization of a yellow fever outbreak in northern Uganda, October 2010-January 2011. Wamala JF, Malimbo M, Okot CL, Atai-Omoruto AD, Tenywa E, Miller JR, Balinandi S, Shoemaker T, Oyoo C, Omony EO, et al. Int J Infect Dis 2012 16 536 e542 10.1016/j.ijid.2012.03.004 22575876
5. Flaviviruses and flavivirus vaccines. Heinz FX, Stiasny K, Vaccine 2012 30 4301 4306 10.1016/j.vaccine.2011.09.114 22682286
6. Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever. Quaresma JAS, Pagliari C, Medeiros DBA, Duarte MIS, Vasconcelos PFC, Rev Med Virol 2013 23 305 318 10.1002/rmv.1752 23873723
7. Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize. Séralini G-E, Clair E, Mesnage R, Gress S, Defarge N, Malatesta M, Hennequin D, de Vendômois JS, Food Chem Toxicol 2012 50 4221 4231 10.1016/j.fct.2012.08.005 22999595
8. Yellow fever burden estimation: Summary. Manuscript in preparation, summary of methods/findings. Garske T, et al. 2013 [ http://www.who.int/csr/ disease/yellowfev/YellowFeverBurdenEstimation-Summary2013.pdf ]
9. New quality and quantity indices in science (NewQIS): the study protocol of an international project. Groneberg-Kloft B, Fischer TC, Quarcoo D, Scutaru C, Jom- J Occup Med (London, England) 2009 4 16
10. Drowning-a scientometric analysis and data acquisition of a constant global problem employing density equalizing mapping and scientometric benchmarking procedures. Groneberg DA, Schilling U, Scutaru C, Uibel S, Zitnik S, Mueller D, Klingelhoefer D, Kloft B, Int J Health Geogr 2011 55 1 10
11. Traffic medicine-related research: a scientometric analysis. Groneberg-Kloft B, Klingelhoefer D, Zitnik SE, Scutaru C, Bmc Public Health 2013 13 541 10.1186/1471-2458-13-541 23734726
12. Density-Equalizing Mapping and Scientometric Benchmarking in industrial health. Scutaru C, Quarcoo D, Takemura M, Welte T, Fischer TC, Groneberg-Kloft B, Ind Health 2010 48 197 203 10.2486/indhealth.48.197 20424350
13. Gout: a critical analysis of scientific development. Gerber A, Groneberg DA, Klingelhofer D, Bundschuh M, Rheumatol Int 2013 33 2743 2750 10.1007/s00296-013-2805-1
14. Influenza: a scientometric and density-equalizing analysis. Fricke R, Uibel S, Klingelhoefer D, Groneberg DA, BMC Infect Dis 2013 13 454 10.1186/1471-2334-13-454 24079616
15. A bibliometric analysis of bipolar affective disorders using density-equalizing mapping and output benchmarking. Vogelzang BH, Scutaru C, Mache S, Vitzthum K, Kusma B, Schulte-Herbruggen O, Groneberg DA, Quarcoo D, Indian J Psychiatry 2012 54 320 326 10.4103/0019-5545.104807 23372233
16. Scientometric analysis and combined density-equalizing mapping of environmental tobacco smoke (ETS) research. Vitzthum K, Scutaru C, Musial-Bright L, Quarcoo D, Welte T, Spallek M, Groneberg-Kloft B, PloS one 2010 5 11254 10.1371/journal.pone.0011254 20582305
17. Quality and quantity indices in science: use of visualization tools. Groneberg-Kloft B, Quarcoo D, Scutaru C, EMBO Rep 2009 10 800 803
18. Cough as a symptom and a disease entity: scientometric analysis and density-equalizing calculations. Groneberg-Kloft B, Dinh QT, Scutaru C, Welte T, Fischer A, Chung KF, Quarcoo D, J Investig Allergol Clin Immunol 2009 19 266 275 19639722
19. Tobacco control: visualisation of research activity using density-equalizing mapping and scientometric benchmarking procedures. Kusma B, Scutaru C, Quarcoo D, Welte T, Fischer TC, Groneberg-Kloft B, Int J Environ Res Public Health 2009 6 1856 1869 10.3390/ijerph6061856 19578464
20. Does the h index have predictive power? Hirsch JE, Proc Natl Acad Sci USA 2007 104 19193 19198 10.1073/pnas.0707962104 18040045
21. An index to quantify an individual's scientific research output. Hirsch JE, Proc Natl Acad Sci U S A 2005 102 16569 16572 10.1073/pnas.0507655102 16275915 (Pubitemid 41688817)
22. The impact factor and using it correctly. Garfield E, Unfallchirurg 1998 101 413 414 9677838 (Pubitemid 28319334)
23. The history and meaning of the journal impact factor. Garfield E, Jama-J Am Med Assoc 2006 295 90 93 10.1001/jama.295.1.90 (Pubitemid 43042694)
24. Strengths and weaknesses of the impact factor of scientific journals. Zarate V, Cerda J, Rev Med Chile 2007 135 1474 1478 18259661
25. Diffusion-based method for producing density-equalizing maps. Gastner MTMTNMEJ, Proc Natl Acad Sci U S A 2004 101 7499 7504 10.1073/pnas.0400280101 15136719 (Pubitemid 38658057)
26. Institutional operating figures in basic and applied sciences: scientometric analysis of quantitative output benchmarking. Groneberg-Kloft B, Scutaru C, Kreiter C, Kolzow S, Fischer A, Quarcoo D, Health res policy and systems / BioMed Central 2008 6 6 10.1186/1478-4505-6-6 (Pubitemid 352025075)
27. The etiology of yellow fever: an additional note. 1901. Reed W, Carroll J, Agramonte A, Mil Med 2001 166 44 53 (Pubitemid 32947355)
28. Homogeneity of yellow fever virus strains isolated during an epidemic and a post-epidemic period in West Africa. Pisano MR, Nicoli J, Tolou H, Virus Genes 1997 14 225 234 10.1023/A:1007987911220 9311567 (Pubitemid 27397058)
29. The use of yellow fever virus modified by in vitro cultivation for human immunization (Reprinted from J Exp Med vol 65, pg 787-800, 1937). Mortimer P, Rev Med Virol 2000 10 3 13 10.1002/(SICI)1099-1654(200001/02)10:1<3::AID- RMV261>3.0.CO;2-O
30. Yellow fever in Bolivia, its history and epidemiology. Bevier G, Torresmunoz N, Doriamedina J, Am J Trop Med Hyg 1953 2 464 482 13040681
31. Outbreak news. Yellow fever, Paraguay. Wkly Epidemiol Rec 2008 83 105 18350685
32. The impact of "Impact Factor" on medical journalism in the developing world. Mohebbi MR, Indian Pediatr 2008 45 604 604 18695286
33. Journal impact factor in the era of expanding literature. Andersen J, Belmont J, Cho CT, J Microbiol Immunol 2006 39 436 443 (Pubitemid 46374208)
34. Bibliometric analysis of leishmaniasis research in Medline (1945-2010). Ramos JM, Gonzalez-Alcaide G, Bolanos-Pizarro M, Parasite Vector 2013 6 55 10.1186/1756-3305-6-55
35. The Malaria in Pregnancy Library: a bibliometric review. Van Eijk AM, Hill J, Povall S, Reynolds A, Wong HL, Ter Kuile FO, Malaria J 2012 11 362 10.1186/1475-2875-11-362
36. ASPH Public Health Rep, [ http://www.asph.org/document.cfm?page=713 ]
37. Frauen in Brasilien. Konrad-Adenauer-Stiftung, http://www.kas.de/wf/doc/ kas-17800-1522-1-30.pdf?091024002708
38. Scorecard on Gender Equality in the Knowledge Society. Huyer S, Hafkin N, [ http://elsevierconnect.com/brazilian-women-lead-in-science-technology-and- innovation-study-shows/ ]